Barbara A Wood sold $5,576 of SLS
EVP, Gen. Counsel, Corp. Sec. at SELLAS Life Sciences Group, Inc.. 2,153 shares at an average of $2.59, traded Dec 5, 2022, filed Dec 5, 2022.
Score components
- +15RoleOfficer
- 0Trade size$6k at market
- 0Share of holdings soldSold 3.7% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-22-124565, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 5, 2022 | SOpen-market sale Class A Common Stock | -2,153 | $2.59 | $5,576 | 56,344 | Dec 5, 2022 |
Related signals
Other insiders at SELLAS Life Sciences Group, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 35Weak | SLSbuy SELLAS Life Sciences Group, Inc. | Katherine Bach Kalin director | $101k 63,400 shares | +155% | |
| 33Weak | SELLAS Life Sciences Group, Inc. | Robert L Van Nostrand director | $15k 10,000 shares | +96% | |
| 46Moderate | SELLAS Life Sciences Group, Inc. | Jane Wasman director | $34k 20,000 shares | +192% | |
| 39Weak | SELLAS Life Sciences Group, Inc. | Katherine Bach Kalin director | $36k 20,000 shares | +95% | |
| 30Weak | SELLAS Life Sciences Group, Inc. | John Thomas Burns Senior VP, Finance & CAO | $3,002 1,159 shares | -4% | |
| 40Moderate | SELLAS Life Sciences Group, Inc. | Angelos M. Stergiou President and CEO | $17k 6,494 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.